BABY — Else Nutrition Holdings Cashflow Statement
0.000.00%
- CA$1.44m
- CA$3.14m
- CA$6.03m
Annual cashflow statement for Else Nutrition Holdings, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -1.62 | -17.6 | -15.6 | -15.2 | -8.88 |
| Depreciation | |||||
| Non-Cash Items | -13.1 | -1.74 | -1.76 | 0.901 | 2.34 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.39 | -2.05 | -1.32 | 4.89 | 3.07 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -15.8 | -20.9 | -18.3 | -9.06 | -3.18 |
| Capital Expenditures | -0.287 | -0.16 | 0 | -0.062 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 1.43 | 0.33 | -1.13 | 2.77 | 0.327 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 1.14 | 0.17 | -1.13 | 2.71 | 0.327 |
| Financing Cash Flow Items | 0.019 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 16.9 | 11.7 | 7.44 | 3.73 | 2.89 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.51 | -8.48 | -11.6 | -2.88 | 0.105 |